In situ hybridization analysis of Dmpk mRNA in adult mouse tissues
- PMID: 15336691
- DOI: 10.1016/j.nmd.2004.03.012
In situ hybridization analysis of Dmpk mRNA in adult mouse tissues
Abstract
Myotonic dystrophy1 (DM1) is an autosomal dominant, multi-system disorder resulting from a CTG repeat expansion located in the 3' untranslated region of DMPK and immediately in the 5' of SIX5. Skeletal muscle, heart and smooth muscle are prominently affected in DM1. Endocrine abnormalities, gonadal atrophy, brain, skin, skeletal, immune and respiratory defects are also features of the disorder. Both DMPK and SIX5 levels are decreased in DM1 patients. Importantly, expression of mutant mRNAs encoding expanded CUG repeats has been shown to alter the activity of CUG repeat binding proteins in DM1. Mouse models have demonstrated that decreased levels of Dmpk, Six5 and the expression of expanded CUG repeats independently contribute to the development of DM1 pathology. However, an important gap in these studies is a lack of clear understanding of the expression pattern of Dmpk. We demonstrate that Dmpk mRNA is expressed in a range of adult mouse tissues that show pathology in DM1 including skeletal muscle, heart, smooth muscle, bone, testis, pituitary, brain, eye, skin, thymus and lung. Thus DMPK loss or CUG repeat expansion could contribute to DM1 pathology to these tissues. Dmpk mRNA is not detected in the ovary, pancreas or kidney. Significantly, Dmpk mRNA is expressed in the intestinal epithelium, cartilage and liver, which have not been reported to show consistent abnormalities in Dmpk(-/-) mice or in transgenic animals expressing CUG repeats. Taken together these data suggest that Dmpk loss or CUG repeat expression per se may not be sufficient to initiate pathology and are consistent with the hypothesis that coexpression of specific CUG repeat binding proteins with the mutant Dmpk mRNA or deregulation of genes such as Six5 that flank the CTG repeat tract may be necessary for DM1 to manifest.
Similar articles
-
Inhibition of myogenesis in transgenic mice expressing the human DMPK 3'-UTR.Hum Mol Genet. 2004 Mar 15;13(6):589-600. doi: 10.1093/hmg/ddh064. Epub 2004 Jan 20. Hum Mol Genet. 2004. PMID: 14734627
-
Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy.Mol Genet Metab. 2001 Sep-Oct;74(1-2):281-91. doi: 10.1006/mgme.2001.3229. Mol Genet Metab. 2001. PMID: 11592825
-
MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.Hum Mol Genet. 2006 Jul 1;15(13):2138-45. doi: 10.1093/hmg/ddl137. Epub 2006 May 24. Hum Mol Genet. 2006. PMID: 16723374
-
Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1.Cell Signal. 2008 Nov;20(11):1935-41. doi: 10.1016/j.cellsig.2008.05.005. Epub 2008 May 18. Cell Signal. 2008. PMID: 18583094 Review.
-
Myotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms.J Neurosci Res. 2008 Jan;86(1):18-26. doi: 10.1002/jnr.21377. J Neurosci Res. 2008. PMID: 17549748 Review.
Cited by
-
Somatic CTG*CAG repeat instability in a mouse model for myotonic dystrophy type 1 is associated with changes in cell nuclearity and DNA ploidy.BMC Mol Biol. 2007 Jul 23;8:61. doi: 10.1186/1471-2199-8-61. BMC Mol Biol. 2007. PMID: 17645799 Free PMC article.
-
Divergent mitochondrial and endoplasmic reticulum association of DMPK splice isoforms depends on unique sequence arrangements in tail anchors.Mol Cell Biol. 2005 Feb;25(4):1402-14. doi: 10.1128/MCB.25.4.1402-1414.2005. Mol Cell Biol. 2005. PMID: 15684391 Free PMC article.
-
Myotonic dystrophy protein kinase (DMPK) prevents ROS-induced cell death by assembling a hexokinase II-Src complex on the mitochondrial surface.Cell Death Dis. 2013 Oct 17;4(10):e858. doi: 10.1038/cddis.2013.385. Cell Death Dis. 2013. PMID: 24136222 Free PMC article.
-
Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1).Int J Mol Sci. 2022 Mar 12;23(6):3081. doi: 10.3390/ijms23063081. Int J Mol Sci. 2022. PMID: 35328504 Free PMC article.
-
DMPK is a New Candidate Mediator of Tumor Suppressor p53-Dependent Cell Death.Molecules. 2019 Sep 1;24(17):3175. doi: 10.3390/molecules24173175. Molecules. 2019. PMID: 31480541 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous